Aneuvas Technologies Inc.

Flagstaff, AZ

UEI
M8LJU8PQNGZ5
CAGE
6XJU8
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
2225 N Gemini Rd, Flagstaff, AZ 86001, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Grant subawards

Prime recipient Prime award Amount Awarded
The Johns Hopkins University We propose to assess and optimize the balloon-stent prototype for aneurysm endovascular treatment by utilizing resources to meet/exceed the acceptable testing… U54EB033664 $2,586,080

Similar vendors

About the company

Aneuvas Technologies Inc., a for-profit corporation based in Flagstaff, Arizona, is a federal grant recipient developing biomedical device coatings and neuro-interventional medical devices for the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The vendor operates as a prime grant recipient (80% of recent awards) and as a sub-recipient on NIH-funded research collaborations; the company has no federal contract prime awards or IDV seats in the source data.

Aneuvas's federal footprint concentrates entirely within the National Institutes of Health. Four of five awards fund NINDS research, with one award supporting the National Institute of Mental Health; the two agencies account for 100% of recent work. The vendor's most recent and largest award is a $435,979 NINDS project grant (awarded September 4, 2026, performance through August 31, 2028) to develop a biocompatible polymer coating (PPODA-QT) for nitinol flow diverters used in endovascular aneurysm treatment, conducted in collaboration with Pivot Medical and under clinical guidance from Barrow Neurological Institute. A second active prime award is a $433,000 NINDS project grant (awarded July 1, 2023, performance completed December 31, 2024) focused on developing and testing a prototype aspiration catheter with an adaptive radially expandable tip for mechanical thrombectomy in large and medium vessel occlusions. Aneuvas also serves as a sub-recipient on a Johns Hopkins University NINDS grant (awarded September 1, 2026) for balloon-stent prototype optimization, testing, and cGMP manufacturing validation. Combined obligated dollars across all federal awards total $5.5 million. Activity is sparse — two awards in 2017, one in 2023, two in 2026 — with only one award (the completed aspiration catheter project) due to reach ultimate completion within the next twenty-four months. Performance locations include Flagstaff, Arizona.

Quick answers

Is Aneuvas Technologies Inc. registered in SAM.gov?

Yes. Aneuvas Technologies Inc.'s SAM.gov registration is active through April 20, 2027.

What is Aneuvas Technologies Inc.'s CAGE code?

Aneuvas Technologies Inc.'s CAGE code is 6XJU8, and its Unique Entity ID (UEI) is M8LJU8PQNGZ5.

What is Aneuvas Technologies Inc.'s most recent federal award?

Aneuvas Technologies Inc.'s most recent federal grant award is Development of a novel biocompatible polymer coating for aneurysm treatment devices (R41NS143513), from National Institute of Neurological Disorders and Stroke (NIH), on September 4, 2026.

On GovTribe

See Aneuvas Technologies Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe